Astex Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainastx.com

Year Founded1999

Employees51 - 200

Annual Revenue$50M - $75M

Astex

Astex (including company regionals)

astx.com

See more website traffic and engagement information

Astex Revenue up to May 2026 is 50M - 75M

revenue generated by Astex top domains

Astex top domains revenue over 3 years

Revenue for Astex top domains

astx.com50M - 75M

See more with Sales Intelligence

Total visits to Astex's top domains

Understand Astex market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

astx.com6.5K

See more with Sales Intelligence

Avg. visit duration in Astex's top domains

Analyze Astex engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

astx.com00:00:16

See more with Sales Intelligence

Avg. pageviews on Astex's top domains

See how Astex keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

astx.com1.82

See more with Sales Intelligence

Astex top competitors by domain

Top similar sites in May 2026, ranked by their affinity

afnm.comCompany NameAffinium PharmaceuticalsEmployees51 - 200HQUnited States, Texas, AustinAnnual revenue$10M - $15MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Astex

These are the website technologies, by industry, used by Astex top domains

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Astex

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTaiho Pharmaceutical Co., Ltd partnered with Astx on Jan 1st '20.Calderasib is being developed in collaboration with Taiho Pharmaceutical and Astex Pharmaceuticals, a subsidiary of Otsuka Pharmaceutical, under an arrangement announced in January 2020.

NewsAstx is developing p53 tumour suppressor protein for cancer treatment on Aug 25th '23.Last month, Merck (MSD) and Astex Pharmaceuticals partnered to develop small molecule candidates to target the p53 tumour suppressor protein for cancer treatment, using the latter's fragment-based drug discovery platform.

NewsAstx partnered with Merck on Jun 14th '20.Astex Pharmaceuticals expands drug discovery collaboration with Merck.